Myosin II is a negative regulator of oligodendrocyte morphological differentiation

Journal of Neuroscience Research

Volumn 90, Issue 8, 2012, Pages 1547-1556

  Wang, Haibo ^a   Rusielewicz, Tomasz ^a,b   Tewari, Ambika ^a   Leitman, Ellen M ^a   Einheber, Steven ^a   Melendez Vasquez, Carmen V ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

CNS; Cytoskeleton; Fyn; Myelination; RhoGTPases

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; BLEBBISTATIN; MYOSIN II; PROTEIN KINASE FYN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SMALL INTERFERING RNA;

ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; KNOCKOUT MOUSE; MORPHOGENESIS; MOUSE; MYELINATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; CELL DIFFERENTIATION; CYTOSKELETON; DOWN-REGULATION; FLUORESCENT ANTIBODY TECHNIQUE; MICE; MICE, KNOCKOUT; MICROSCOPY, IMMUNOELECTRON; MYOSIN TYPE II; NEURAL STEM CELLS; NEUROGENESIS; OLIGODENDROGLIA; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-FYN; RATS; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84862795076     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23036     Document Type: Article

References (53)

1. Alabed YZ, Grados-Munro E, Ferraro GB, Hsieh SH, Fournier AE. 2006. Neuronal responses to myelin are mediated by rho kinase. J Neurochem 96: 1616-1625.
2. Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T, Matsuura Y, Kaibuchi K. 1996. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 271: 20246-20249.
3. Baer AS, Syed YA, Kang SU, Mitteregger D, Vig R, Ffrench-Constant C, Franklin RJ, Altmann F, Lubec G, Kotter MR. 2009. Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling. Brain 132: 465-481.
4. Bauer NG, Richter-Landsberg C, Ffrench-Constant C. 2009. Role of the oligodendroglial cytoskeleton in differentiation and myelination. Glia 57: 1691-1705.
5. Behar TN. 2001. Analysis of fractal dimension of O2A glial cells differentiating in vitro. Methods 24: 331-339.
6. Benninger Y, Thurnherr T, Pereira JA, Krause S, Wu X, Chrostek-Grashoff A, Herzog D, Nave KA, Franklin RJ, Meijer D, Brakebusch C, Suter U, Relvas JB. 2007. Essential and distinct roles for cdc42 and rac1 in the regulation of Schwann cell biology during peripheral nervous system development. J Cell Biol 177: 1051-1061.
7. Bito H, Furuyashiki T, Ishihara H, Shibasaki Y, Ohashi K, Mizuno K, Maekawa M, Ishizaki T, Narumiya S. 2000. A critical role for a Rho-associated kinase, p160ROCK, in determining axon outgrowth in mammalian CNS neurons. Neuron 26: 431-441.
8. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, Christopherson KS, Xing Y, Lubischer JL, Krieg PA, Krupenko SA, Thompson WJ, Barres BA. 2008. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci 28: 264-278.
9. Chen Y, Balasubramaniyan V, Peng J, Hurlock EC, Tallquist M, Li J, Lu QR. 2007. Isolation and culture of rat and mouse oligodendrocyte precursor cells. Nat Protoc 2: 1044-1051.
10. Clark K, Langeslag M, Figdor CG, van Leeuwen FN. 2007. Myosin II and mechanotransduction: a balancing act. Trends Cell Biol 17: 178-186.
11. Colognato H, Ramachandrappa S, Olsen IM, Ffrench-Constant C. 2004. Integrins direct Src family kinases to regulate distinct phases of oligodendrocyte development. J Cell Biol 167: 365-375.
12. Conti MA, Adelstein RS. 2008. Nonmuscle myosin II moves in new directions. J Cell Sci 121: 11-18.
13. Conti MA, Even-Ram S, Liu C, Yamada KM, Adelstein RS. 2004. Defects in cell adhesion and the visceral endoderm following ablation of nonmuscle myosin heavy chain II-A in mice. J Biol Chem 279: 41263-41266.
14. Dugas JC, Tai YC, Speed TP, Ngai J, Barres BA. 2006. Functional genomic analysis of oligodendrocyte differentiation. J Neurosci 26: 10967-10983.
15. Dugas JC, Ibrahim A, Barres BA. 2007. A crucial role for p57(Kip2) in the intracellular timer that controls oligodendrocyte differentiation. J Neurosci 27: 6185-6196.
16. Einheber S, Schnapp LM, Salzer JL, Cappiello ZB, Milner TA. 1996. Regional and ultrastructural distribution of the alpha 8 integrin subunit in developing and adult rat brain suggests a role in synaptic function. J Comp Neurol 370: 105-134.
17. Engler AJ, Sen S, Sweeney HL, Discher DE. 2006. Matrix elasticity directs stem cell lineage specification. Cell 126: 677-689.
18. Feltri ML, Suter U, Relvas JB. 2008. The function of RhoGTPases in axon ensheathment and myelination. Glia 56: 1508-1517.
19. Fischer RS, Gardel M, Ma X, Adelstein RS, Waterman CM. 2009. Local cortical tension by myosin II guides 3D endothelial cell branching. Curr Biol 19: 260-265.
20. Fox MA, Afshari FS, Alexander JK, Colello RJ, Fuss B. 2006. Growth conelike sensorimotor structures are characteristic features of postmigratory, premyelinating oligodendrocytes. Glia 53: 563-566.
21. Haviv L, Gillo D, Backouche F, Bernheim-Groswasser A. 2008. A cytoskeletal demolition worker: myosin II acts as an actin depolymerization agent. J Mol Biol 375: 325-330.
22. Hirose M, Ishizaki T, Watanabe N, Uehata M, Kranenburg O, Moolenaar WH, Matsumura F, Maekawa M, Bito H, Narumiya S. 1998. Molecular dissection of the Rho-associated protein kinase (p160ROCK)-regulated neurite remodeling in neuroblastoma N1E-115 cells. J Cell Biol 141: 1625-1636.
23. Hsu SM, Raine L, Fanger H. 1981. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29: 577-580.
24. Kachar B, Behar T, Dubois-Dalcq M. 1986. Cell shape and motility of oligodendrocytes cultured without neurons. Cell Tissue Res 244: 27-38.
25. Kim HJ, DiBernardo AB, Sloane JA, Rasband MN, Solomon D, Kosaras B, Kwak SP, Vartanian TK. 2006. WAVE1 is required for oligodendrocyte morphogenesis and normal CNS myelination. J Neurosci 26: 5849-5859.
26. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Feng J, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K. 1996. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273: 245-248.
27. Kippert A, Trajkovic K, Rajendran L, Ries J, Simons M. 2007. Rho regulates membrane transport in the endocytic pathway to control plasma membrane specialization in oligodendroglial cells. J Neurosci 27: 3560-3570.
28. Kippert A, Fitzner D, Helenius J, Simons M. 2009. Actomyosin contractility controls cell surface area of oligodendrocytes. BMC Cell Biol 10: 71.
29. Kuo JC, Han X, Hsiao CT, Yates JR3rd, Waterman CM. 2011. Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for beta-Pix in negative regulation of focal adhesion maturation. Nat Cell Biol 13: 383-393.
30. Laursen LS, Chan CW, Ffrench-Constant C. 2009. An integrin-contactin complex regulates CNS myelination by differential Fyn phosphorylation. J Neurosci 29: 9174-9185.
31. Leitman EM, Tewari A, Horn M, Urbanski M, Damanakis E, Einheber S, Salzer JL, de Lanerolle P, Melendez-Vasquez CV. 2011. MLCK regulates Schwann cell cytoskeletal organization, differentiation and myelination. J Cell Sci 124: 3784-3796.
32. Liang X, Draghi NA, Resh MD. 2004. Signaling from integrins to Fyn to Rho family GTPases regulates morphologic differentiation of oligodendrocytes. J Neurosci 24: 7140-7149.
33. Loudon RP, Silver LD, Yee HFJr, Gallo G. 2006. RhoA-kinase and myosin II are required for the maintenance of growth cone polarity and guidance by nerve growth factor. J Neurobiol 66: 847-867.
34. Medeiros NA, Burnette DT, Forscher P. 2006. Myosin II functions in actin-bundle turnover in neuronal growth cones. Nat Cell Biol 8: 215-226.
35. Melendez-Vasquez CV, Einheber S, Salzer JL. 2004. Rho kinase regulates schwann cell myelination and formation of associated axonal domains. J Neurosci 24: 3953-3963.
36. Miyamoto Y, Yamauchi J, Chan JR, Okada A, Tomooka Y, Hisanaga S, Tanoue A. 2007. Cdk5 regulates differentiation of oligodendrocyte precursor cells through the direct phosphorylation of paxillin. J Cell Sci 120: 4355-4366.
37. Niederost B, Oertle T, Fritsche J, McKinney RA, Bandtlow CE. 2002. Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1. J Neurosci 22: 10368-10376.
38. Nodari A, Zambroni D, Quattrini A, Court FA, D'Urso A, Recchia A, Tybulewicz VL, Wrabetz L, Feltri ML. 2007. Beta1 integrin activates Rac1 in Schwann cells to generate radial lamellae during axonal sorting and myelination. J Cell Biol 177: 1063-1075.
39. Osterhout DJ, Wolven A, Wolf RM, Resh MD, Chao MV. 1999. Morphological differentiation of oligodendrocytes requires activation of Fyn tyrosine kinase. J Cell Biol 145: 1209-1218.
40. Pereira JA, Benninger Y, Baumann R, Goncalves AF, Ozcelik M, Thurnherr T, Tricaud N, Meijer D, Fassler R, Suter U, Relvas JB. 2009. Integrin-linked kinase is required for radial sorting of axons and Schwann cell remyelination in the peripheral nervous system. J Cell Biol 185: 147-161.
41. Pfeiffer SE, Warrington AE, Bansal R. 1993. The oligodendrocyte and its many cellular processes. Trends Cell Biol 3: 191-197.
42. Rajasekharan S, Baker KA, Horn KE, Jarjour AA, Antel JP, Kennedy TE. 2009. Netrin 1 and Dcc regulate oligodendrocyte process branching and membrane extension via Fyn and RhoA. Development 136: 415-426.
43. Sloane JA, Vartanian TK. 2007. Myosin Va controls oligodendrocyte morphogenesis and myelination. J Neurosci 27: 11366-11375.
44. Somlyo AP, Somlyo AV. 2000. Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 522: 177-185.
45. Song J, Goetz BD, Baas PW, Duncan ID. 2001. Cytoskeletal reorganization during the formation of oligodendrocyte processes and branches. Mol Cell Neurosci 17: 624-636.
46. Sperber BR, McMorris FA. 2001. Fyn tyrosine kinase regulates oligodendroglial cell development but is not required for morphological differentiation of oligodendrocytes. J Neurosci Res 63: 303-312.
47. Straight AF, Cheung A, Limouze J, Chen I, Westwood NJ, Sellers JR, Mitchison TJ. 2003. Dissecting temporal and spatial control of cytokinesis with a myosin II inhibitor. Science 299: 1743-1747.
48. Tullio AN, Accili D, Ferrans VJ, Yu ZX, Takeda K, Grinberg A, Westphal H, Preston YA, Adelstein RS. 1997. Nonmuscle myosin II-B is required for normal development of the mouse heart. Proc Natl Acad Sci U S A 94: 12407-12412.
49. Tullio AN, Bridgman PC, Tresser NJ, Chan CC, Conti MA, Adelstein RS, Hara Y. 2001. Structural abnormalities develop in the brain after ablation of the gene encoding nonmuscle myosin II-B heavy chain. J Comp Neurol 433: 62-74.
50. Umemori H, Kadowaki Y, Hirosawa K, Yoshida Y, Hironaka K, Okano H, Yamamoto T. 1999. Stimulation of myelin basic protein gene transcription by Fyn tyrosine kinase for myelination. J Neurosci 19: 1393-1397.
51. Wang H, Tewari A, Einheber S, Salzer JL, Melendez-Vasquez CV. 2008. Myosin II has distinct functions in PNS and CNS myelin sheath formation. J Cell Biol 182: 1171-1184.
52. Wolf RM, Wilkes JJ, Chao MV, Resh MD. 2001. Tyrosine phosphorylation of p190 RhoGAP by Fyn regulates oligodendrocyte differentiation. JNeurobiol 49: 62-78.
53. Wu D, Asiedu M, Adelstein RS, Wei Q. 2006. A novel guanine nucleotide exchange factor MyoGEF is required for cytokinesis. Cell Cycle 5: 1234-1239.